Emerging technologies are disrupting every industry, with no exception to biomedical industry in Asia. Early stage biotech companies including Strand Lifesciences are tapping onto this latest trend to provide innovative tools and strategies to improve how stakeholders work in the industry. Vijay Chandru, Executive Chairman of Strand Lifescience joined us at the 14th BioPharma India, Mumbai on 15-16 November 2016. In case …
